Health news
Policy reforms and legislation to enhance the authority of pharmacists to administer vaccines may lead to increased immunization rates among individuals in low-income communities, especially older adults. These findings were published in the Journal of…
The aluminum phosphate-adjuvanted inactivated enterovirus 71 (EV71) vaccine was highly effective for the prevention of EV71-associated infections among infants and children. These findings, from a phase 3 trial, were published in The Lancet. This prospective,…
Results of a retrospective review found that the field effectiveness (FE) of tick-borne encephalitis (TBE) vaccination may be decreased among patients with severe TBE infection, especially children. These findings were published in the Journal of…
Heterologous COVID-19 vaccination with the ChAdOx1 nCoV-19 and BNT162b2 vaccines increases in vitro neutralizing activity and may confer cross-protection against endemic seasonal human coronaviruses (hCoV), according to results of a study published in Clinical Infectious…
Among patients in South Africa who contracted SARS-CoV-2 infection during the wave dominated by the Omicron (B.1.1529) variant, fewer required hospitalization, supplemental oxygen, or transfer to an intensive care unit (ICU) compared with previous waves,…
Influenza vaccination reduces the risk of serious illness in children even when the circulating virus is antigenically different from the vaccine virus, according to a Centers for Disease Control and Prevention (CDC) study published in…
A single dose of Ad5-nCoV, an adenovirus type 5 (Ad5) vectored vaccine expressing the SARS-CoV-2 spike protein, was found to be efficacious and safe for adults aged 18 years and older, according to results from…
After the introduction of a national human papillomavirus (HPV) immunization program in England, there was a significant decrease in cervical cancer diagnoses and incidence of grade 3 cervical intraepithelial neoplasia (CIN3) in young women, according…
On Tuesday, November 2, the CDC Advisory Committee on Immunization Practices (ACIP) recommended the Pfizer-BioNTech pediatric vaccine for children aged 5 to 11 years. This was the latest hurdle in the race to vaccinate all Americans to…
In anticipation of authorization of COVID-19 vaccines to children younger than 12 years, the National Academies of Sciences, Engineering, and Medicine (NASEM) released a new rapid expert consultation for communications with parents. Strategies include pointing…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021